Atlas Trials

The Safety ,Tolerability and Efficacy Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver Failure

Clinical trial NCT05989958 · RECRUITING

Trial details

NCT number
NCT05989958
Sponsor
Hexaell Biotech Co., Ltd.
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Acute on Chronic Hepatic FailureLiver FailureHepatitis
Start date
2023-09-22
Primary completion
2026-09-01
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.